말 헬스케어 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 적응증별, 활동별, 유통 채널별, 지역별, 부문별 예측(2026-2033년)

Equine Healthcare Market Summary

The global equine healthcare market size was estimated at USD 4.56 billion in 2025 and is projected to reach USD 10.40 billion by 2033, growing at a CAGR of 10.93% from 2026 to 2033. The industry is primarily driven by the increasing equine sports activities, growing prevalence of diseases in equine population, increasing equine sports activities, and growing uptake of horse insurance.

Increasing awareness of feed quality and life-stage-specific nutrition is driving demand for specialized supplements and feed balancers. For instance, in September 2025, Simple System Horse Feeds launched Stud Balance +, a nutrient-rich feed balancer designed to support broodmares, stallions, and young horses with protein and calcium for growth, reproduction, and lactation needs.

The growing number of competitive and recreational equestrian events, both nationally and internationally, is fueling the demand for high-quality equine care. For instance, according to an article published by The Association of Summer Olympic International Federations, in April 2025, the Federation Equestre Internationale (FEI) took a significant step by signing two strategic Memoranda of Understanding (MoUs) with China's leading media organizations, Xinhua News Agency and China Media Group (CMG). These agreements were formalized during a high-level visit by FEI President Ingmar De Vos and Secretary General Sabrina Ibanez and aim to strengthen the promotion of equestrian sport through enhanced reporting, integrated media content, and exclusive programming rights.

This increased visibility and professionalization of equestrian sport is expected to directly drive the equine healthcare market. Greater media exposure and international competition participation raise awareness around horse performance, welfare, and injury prevention, thereby increasing demand for veterinary services, diagnostics, pharmaceuticals, vaccines, and advanced equine healthcare solutions. As Chinese athletes prepare for elite global events under heightened public and institutional scrutiny, investments in preventive care, sports medicine, rehabilitation, and nutrition for horses are likely to rise. Consequently, initiatives such as the FEI's partnerships with Xinhua and CMG promote equestrian sport and act as a catalyst for long-term growth in the equine healthcare market by highlighting the importance of good quality medical care and welfare standards for performance horses.

Global Equine Healthcare Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global equine healthcare market report based on product, indication, activity, distribution channel, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceuticals
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory & Analgesics
  • Other Pharmaceuticals
• Vaccines
• Medicinal Feed Additives
• Orthobiologics
• Diagnostics
  • Diagnostic Test Kits
  • Diagnostics Equipment
• Software & Services
  • Practice Management Software
  • Imaging Software
  • Telehealth Software
  • Other Software
• Others
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Musculoskeletal Disorders
• Parasitic Infections
• Equine Herpes Virus
• Equine Viral Arteritis (EVA)
• Equine Influenza
• West Nile Virus
• Tetanus
• Other Indications
• Activity Outlook (Revenue, USD Million, 2021 - 2033)
• Sports/ Racing
• Recreation
• Other Activities
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals & Clinics
• E-commerce
• Equesterian Facilities
• Other Channels
• Equine Healthcare Market Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Indication
  • 1.2.3. Activity
  • 1.2.4. Distribution Channel
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1 Analysis
  • 1.7.2. Model 2 Analysis
  • 1.7.3. Model 3 Analysis
• 1.8. List of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Sports Activities Of Equine
    • 3.2.1.2. Rising Awareness Of Preventive Healthcare And Nutrition
    • 3.2.1.3. Advances In Veterinary Medicine And Technology
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Treatment Costs And Limited Accessibility
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL by SWOT Analysis
• 3.4. Technology Trend Analysis
• 3.5. Pricing Analysis
• 3.6. Product Pipeline/ Clinical Trials Analysis
• 3.7. Estimated Equine Population by key Countries, 2025

Chapter 4. Equine Healthcare Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Equine Healthcare Market: Product Movement Analysis
• 4.3. Equine Healthcare Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
• 4.4. Pharmaceuticals
  • 4.4.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Parasiticides
    • 4.4.2.1. Parasiticides Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Anti-infectives
    • 4.4.3.1. Anti-infectives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Anti-inflammatory & Analgesics
    • 4.4.4.1. Anti-inflammatory & Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Other Pharmaceuticals
    • 4.4.5.1. Other Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Vaccines
  • 4.5.1. Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Medicinal Feed Additives
  • 4.6.1. Medicinal Feed Additives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Orthobiologics
  • 4.7.1. Orthobiologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Diagnostics
  • 4.8.1. Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.2. Diagnostic Test Kits
    • 4.8.2.1. Diagnostic Test Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.3. Diagnostics Equipment
    • 4.8.3.1. Diagnostics Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Software & Services
  • 4.9.1. Software & Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.2. Practice Management Software
  • 4.9.3. Practice Management Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.4. Imaging Software
    • 4.9.4.1. Imaging Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.5. Telehealth Software
    • 4.9.5.1. Telehealth Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.6. Other Software
    • 4.9.6.1. Other Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Others
  • 4.10.1.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Equine Healthcare Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Equine Healthcare Market: Indication Movement Analysis
• 5.3. Equine Healthcare Market Size & Trend Analysis, by Indication 2021 to 2033 (USD Million)
• 5.4. Musculoskeletal Disorders
  • 5.4.1. Musculoskeletal Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Parasitic Infections
  • 5.5.1. Parasitic Infections Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Equine Herpes Virus
  • 5.6.1. Equine Herpes Virus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Equine Viral Arteritis (EVA)
  • 5.7.1. Equine Viral Arteritis (EVA) Market Estimates and Forecasts, 2021 - 2033(USD Million )
• 5.8. Equine Influenza
  • 5.8.1. Equine Influenza Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. West Nile Virus
  • 5.9.1. West Nile Virus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Tetanus
  • 5.10.1. Tetanus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.11. Other Indications
  • 5.11.1. Other Indications Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Equine Healthcare Market: By Activity Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Equine Healthcare Market: By Activity Movement Analysis
• 6.3. Equine Healthcare Market Size & Trend Analysis, by Activity, 2021 to 2033 (USD Million)
  • 6.3.1. Sports/ Racing
    • 6.3.1.1. Sports/ Racing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Recreation
    • 6.3.2.1. Recreation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Others
    • 6.3.3.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Equine Healthcare Market: By Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Equine Healthcare Market: By Distribution Channel Movement Analysis
• 7.3. Equine Healthcare Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 7.3.1. Veterinary Hospitals & Clinics
    • 7.3.1.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. E-commerce
    • 7.3.2.1. E-commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Equesterian Facilities
    • 7.3.3.1. Equesterian Facilities Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Others
    • 7.3.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Equine Healthcare Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Equine Healthcare Market Share, By Region, 2025 & 2033, USD Million
• 8.3. Regional Outlook
• 8.4. North America
  • 8.4.1. North America Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Insights
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. U.S. Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Insights
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Canada Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Insights
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Insights
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. UK Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Insights
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Germany Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Insights
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. France Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Insights
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Italy Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Insights
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Spain Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Insights
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Denmark Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Insights
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Sweden Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Insights
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Norway Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Insights
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Japan Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Insights
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. China Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Insights
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. India Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Insights
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Australia Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Insights
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. South Korea Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Insights
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Thailand Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Insights
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Brazil Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Insights
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Argentina Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Insights
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. South Africa Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Insights
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Saudi Arabia Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Insights
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. UAE Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Insights
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Kuwait Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8.6. Qatar
    • 8.8.6.1. Key Country Dynamics
    • 8.8.6.2. Competitive Insights
    • 8.8.6.3. Regulatory Framework
    • 8.8.6.4. Qatar Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8.7. Oman
    • 8.8.7.1. Key Country Dynamics
    • 8.8.7.2. Competitive Insights
    • 8.8.7.3. Regulatory Framework
    • 8.8.7.4. Oman Equine Healthcare Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Company Market Position Analysis/ Heat Map Analysis, 2025
• 9.3. Company Profiles
  • 9.3.1. Boehringer Ingelheim International GmbH.
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Zoetis Services LLC
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Dechra
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Arthrex Inc.
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Ceva Sante Animale
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Heska Corporation
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Merck & Co. Inc
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Esaote SPA
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. IDEXX Laboratories, Inc.
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Covetrus
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives
  • 9.3.11. Elanco
    • 9.3.11.1. Participant's Overview
    • 9.3.11.2. Financial Performance
    • 9.3.11.3. Product Benchmarking
    • 9.3.11.4. Strategic Initiatives
  • 9.3.12. Cargill
    • 9.3.12.1. Participant's Overview
    • 9.3.12.2. Financial Performance
    • 9.3.12.3. Product Benchmarking
    • 9.3.12.4. Strategic Initiatives
• 9.4. List of other key players